News and Announcements
The Pulse appoint Foxtel’s, Dillon Hicks as Head of Production
- Published July 30, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- The Pulse appoints Dillon Hicks as Head of Production, a newly created role.
- Dillon Hicks was the Head of Production at Foxtel where he was instrumental in the successful “Make it Yours” campaign.
- Hicks will enable the company to capitalise on their launching of world-first collaborative VR platform.
The Pulse has announced the appointment of Dillon Hicks as their Head of Production. The former Head of Production at Foxtel, Hicks will now lead The Pulse’s team of developers, artists and designers to deliver cutting-edge communication across education, corporate training, health and entertainment platforms. The newly created position of Head of Production demonstrates the company’s continual growth in the technology sector.
Hicks was a founding member of the in-house Foxtel agency, Felix. The leadership team launched the campaign “Make it Yours” and played key roles in launching successful Foxtel products and advertisements. He was also Head of Production at Moon Communications where he established a high-volume integrated production offering, to service its newly acquired Westfield account. Joining The Pulse team, Hicks will explore storytelling in a mixed reality space. The company is set to launch a collaborative virtual reality (VR) platform, and Hick’s appointment allows the company to capitalise on the opportunities ahead of this.
About the Pulse IQ
The Pulse IQ is a world first, device-agnostic platform for the delivery of immersive and collaborative Virtual Reality content for training and education.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
